| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $780K | -33.7% |
| Cost of Revenue | $778K | -12.5% |
| Gross Profit | $2K | -99.3% |
| R&D Expense | $1.3M | -20.7% |
| SG&A Expense | $3.2M | -33.4% |
| Operating Income | -$5.7M | +31.3% |
| Net Income | -$5.7M | +31.4% |
| EPS (Basic) | -$19.68 | -89.2% |
| EPS (Diluted) | -$19.68 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -41.0% |
| Accounts Receivable | $69K | -60.3% |
| Inventory | $319K | -57.8% |
| Current Assets | $2.6M | -43.3% |
| Total Assets | $2.8M | -45.6% |
| Current Liabilities | $272K | -80.6% |
| Total Liabilities | $272K | -82.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | +32.7% |
| Capital Expenditures | $118K | +0.0% |
| Investing Cash Flow | -$118K | +0.0% |
| Financing Cash Flow | $4.3M | -49.1% |
| Free Cash Flow | -$5.8M | +32.3% |
| -89.2% |
| Stockholders' Equity |
| $2.5M |
| -29.2% |